Latest Insider Transactions at Metsera, Inc. (MTSR)
This section provides a real-time view of insider transactions for Metsera, Inc. (MTSR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Metsera, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Metsera, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 13
2025
|
Fmr LLC |
SELL
Other acquisition or disposition
|
Indirect |
2,233,460
-100.0%
|
-
|
|
Nov 13
2025
|
Arch Venture Partners Xii, LLC Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
26,816,808
-100.0%
|
-
|
|
Nov 13
2025
|
Matthew Lang CHIEF LEGAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,500
-100.0%
|
-
|
|
Nov 13
2025
|
Paul L Berns |
SELL
Sale (or disposition) back to the issuer
|
Direct |
961,590
-100.0%
|
-
|
|
Nov 13
2025
|
Paul L Berns |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
15,837,362
-100.0%
|
-
|
|
Nov 13
2025
|
Steven Marso CHIEF MEDICAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,000
-100.0%
|
-
|
|
Nov 13
2025
|
Population Health Partners Gp, LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
12,639,787
-100.0%
|
-
|
|
Nov 13
2025
|
Population Health Partners Gp, LLC |
SELL
Sale (or disposition) back to the issuer
|
Direct |
127,675
-100.0%
|
-
|
|
Nov 13
2025
|
Kristina Burow |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
51,411,394
-100.0%
|
-
|
|
Nov 13
2025
|
Kristina Burow |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,688
-100.0%
|
-
|
|
Nov 13
2025
|
Christopher Whitten Bernard |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
12,767,462
-100.0%
|
-
|
|
Nov 13
2025
|
Christopher Whitten Bernard |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,250
-100.0%
|
-
|
|
Nov 13
2025
|
Clive Meanwell EXECUTIVE CHAIRMAN |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
12,767,462
-100.0%
|
-
|
|
Nov 13
2025
|
Clive Meanwell EXECUTIVE CHAIRMAN |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,375
-100.0%
|
-
|
|
Nov 13
2025
|
Christopher Visioli CHIEF FINANCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,250
-100.0%
|
-
|
|
Nov 13
2025
|
Brian Hubbard CHIEF SCIENTIFIC OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,000
-100.0%
|
-
|
|
Nov 13
2025
|
Jon P Stonehouse |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,688
-100.0%
|
-
|
|
Nov 13
2025
|
Joshua Pinto |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,688
-100.0%
|
-
|
|
Nov 11
2025
|
Validae Health, L.P. |
SELL
Other acquisition or disposition
|
Direct |
12,767,462
-100.0%
|
-
|
|
Nov 10
2025
|
Fmr LLC |
SELL
Bona fide gift
|
Indirect |
860,722
-27.84%
|
-
|
|
Nov 03
2025
|
Fmr LLC |
BUY
Other acquisition or disposition
|
Indirect |
5,023,572
+46.78%
|
-
|
|
Nov 03
2025
|
Fmr LLC |
SELL
Other acquisition or disposition
|
Indirect |
5,593,464
-100.0%
|
-
|
|
Nov 03
2025
|
Fmr LLC |
SELL
Open market or private sale
|
Indirect |
193
-0.01%
|
$11,773
$61.23 P/Share
|
|
Oct 06
2025
|
Fmr LLC |
SELL
Bona fide gift
|
Indirect |
633,715
-57.22%
|
-
|
|
Sep 02
2025
|
Fmr LLC |
BUY
Other acquisition or disposition
|
Indirect |
2,151,820
+50.0%
|
-
|
|
Sep 02
2025
|
Fmr LLC |
SELL
Open market or private sale
|
Indirect |
268
-100.0%
|
$9,648
$36.0 P/Share
|
|
Sep 02
2025
|
Fmr LLC |
SELL
Other acquisition or disposition
|
Indirect |
2,367,294
-76.57%
|
-
|
|
Sep 02
2025
|
Fmr LLC |
BUY
Other acquisition or disposition
|
Indirect |
895
+50.0%
|
-
|
|
Feb 03
2025
|
Fmr LLC |
BUY
Conversion of derivative security
|
Indirect |
4,539,540
+45.37%
|
-
|
|
Feb 03
2025
|
Kristina Burow |
BUY
Open market or private purchase
|
Indirect |
2,222,222
+7.93%
|
$39,999,996
$18.0 P/Share
|
|
Feb 03
2025
|
Kristina Burow |
BUY
Conversion of derivative security
|
Indirect |
23,530,631
+49.2%
|
-
|
|
Feb 03
2025
|
Arch Venture Partners Xii, LLC Director |
BUY
Open market or private purchase
|
Indirect |
2,222,222
+7.93%
|
$39,999,996
$18.0 P/Share
|
|
Feb 03
2025
|
Arch Venture Partners Xii, LLC Director |
BUY
Conversion of derivative security
|
Indirect |
23,530,631
+49.2%
|
-
|
|
Feb 03
2025
|
Paul L Berns |
BUY
Open market or private purchase
|
Indirect |
789,998
+8.68%
|
$14,219,964
$18.0 P/Share
|
|
Feb 03
2025
|
Paul L Berns |
BUY
Conversion of derivative security
|
Indirect |
7,523,682
+50.0%
|
-
|
|
Jan 30
2025
|
Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P. |
BUY
Conversion of derivative security
|
Direct |
1,857,699
+50.0%
|
-
|